BioStock: CombiGene comments on Eurostars funding

CombiGene, together with its Danish partner Zyneyro, has received welcome financial support of 8,6 million SEK from Eurostars for the continued development of the peptide COZY1, a drug candidate for the treatment of severe chronic pain conditions. BioStock reached out to CombiGene’s CEO Peter Ekolind for a comment.

Read the full interview with Peter Ekolind at biostock.se:

https://www.biostock.se/en/2023/12/combigene-comments-on-eurostars-funding/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/